Crossmark

Augmenting the safety and therapeutic efficacy of doxycycline and rifampicin-loaded solid lipid nanoparticles against Brucella abortus using murine model

Crossref DOI link: https://doi.org/10.1186/s43094-024-00753-8

Published Online: 2024-12-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Himani, K. M.

Anbazhagan, Subbaiyan

Prakasan, Lakshmi

Thomas, Prasad

Kumar, Akhilesh https://orcid.org/0000-0001-9601-8819
Narayanan, Krishnaswamy

Singh, Praveen

Chaudhuri, Pallab
License Information

Text and Data Mining valid from 2024-12-23

Version of Record valid from 2024-12-23
More Information

Article History

Received: 1 October 2024

Accepted: 8 December 2024

First Online: 23 December 2024

Declarations

:

: This work was approved by the Institutional Animal Ethics Committee, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly-243122 (No.F. IAEC/10.03.2023/S9).

: The authors declare no conflict of interest.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below